Log in to search using one of your social media accounts:

 

Estimation of Vitamin A Stores in Children and Women in Guatemala and Relation With Potential Toxicity Markers
Condition:   Vitamin A Status Interventions:   Other: High Vitamin A intake;   Other: Normal Vitamin A intake Sponsors:   Institute of Nutrition of Central America and Panama;   Newcastle University;   Bill and Melinda Gates Foundation;   International Atomic Energy Agency Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Condition:   Metastatic Hormone-Sensitive Prostate Cancer Interventions:   Drug: docetaxel 50mg/m2;   Drug: docetaxel 75mg/m2 Sponsor:   Peng Wang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

Estimation of Vitamin A Stores in Children and Women in Guatemala and Relation With Potential Toxicity Markers
Condition:   Vitamin A Status Interventions:   Other: High Vitamin A intake;   Other: Normal Vitamin A intake Sponsors:   Institute of Nutrition of Central America and Panama;   Newcastle University;   Bill and Melinda Gates Foundation;   International Atomic Energy Agency Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2017 Category: Research Source Type: clinical trials

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Conditions:   Progression-free Survival;   Overall Survival;   Toxicity Interventions:   Drug: pegylated liposomal doxorubicin;   Drug: pirarubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Chinese PLA General Hospital;   Beijing Jishuitan Hospital;   Xijing Hospital;   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Utility of High Flow Nasal Cannula in CO Toxicity
Conditions:   Carbon Monoxide Poisoning;   Environmental Exposure Intervention:   Device: Fisher&Paykel AIRVO ™ 2 High Flow Nasal Cannula Therapy Sponsor:   Kocaeli University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Conditions:   Progression-free Survival;   Overall Survival;   Toxicity Interventions:   Drug: pegylated liposomal doxorubicin;   Drug: pirarubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Chinese PLA General Hospital;   Beijing Jishuitan Hospital;   Xijing Hospital;   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Utility of High Flow Nasal Cannula in CO Toxicity
Conditions:   Carbon Monoxide Poisoning;   Environmental Exposure Intervention:   Device: Fisher&Paykel AIRVO ™ 2 High Flow Nasal Cannula Therapy Sponsor:   Kocaeli University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Conditions:   Progression-free Survival;   Overall Survival;   Toxicity Interventions:   Drug: pegylated liposomal doxorubicin;   Drug: pirarubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Chinese PLA General Hospital;   Beijing Jishuitan Hospital;   Xijing Hospital;   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Utility of High Flow Nasal Cannula in CO Toxicity
Conditions:   Carbon Monoxide Poisoning;   Environmental Exposure Intervention:   Device: Fisher&Paykel AIRVO ™ 2 High Flow Nasal Cannula Therapy Sponsor:   Kocaeli University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Conditions:   Progression-free Survival;   Overall Survival;   Toxicity Interventions:   Drug: pegylated liposomal doxorubicin;   Drug: pirarubicin Sponsors:   Peking University People's Hospital;   Peking University Shougang Hospital;   Chinese PLA General Hospital;   Beijing Jishuitan Hospital;   Xijing Hospital;   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2017 Category: Research Source Type: clinical trials

Neurovascular Changes Induced by Chemotherapy
Conditions:   Breast Cancer;   Chemotherapeutic Toxicity Intervention:   Other: Chemotherapy Sponsor:   University of Sao Paulo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen
Conditions:   HIV Seropositivity;   HIV Infections;   HIV-1-infection Interventions:   Drug: Raltegravir;   Drug: Lamivudine Sponsors:   David Garcia Cinca;   Fundació Clínic per a la Recerca Biomèdica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion
Conditions:   Heavy Metal Toxicity;   Spontaneous Abortion Intervention:   Other: observation Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Cytogenetic Damage in Buccal Cells Caused by Toothpaste
Condition:   Toxicity Intervention:   Other: Toothpaste non-fluoride and fluoride Sponsor:   University of Split, School of Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2017 Category: Research Source Type: clinical trials